Ironwood Pharmaceuticals (IRWD) Restructuring Costs (2018 - 2026)
Ironwood Pharmaceuticals (IRWD) reported Restructuring Costs of -$40000.0 for Q1 2026, down 100.22% on a YoY basis from $18.6 million in Q1 2025, and up 84.13% sequentially from -$252000.0 in Q4 2025.
Ironwood Pharmaceuticals (IRWD) Restructuring Costs (2018 - 2026) Analysis & Trends
Ironwood Pharmaceuticals (IRWD) has 8 years of Restructuring Costs data on file, last reported at -$40000.0 in Q1 2026.
- For the quarter ending Q1 2026, Restructuring Costs fell 100.22% year-over-year to -$40000.0; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 92.0% YoY), and the FY2025 full-year result was $20.3 million, up 681.22% from the prior year.
- Restructuring Costs improved to -$40000.0 in Q1 2026, from -$252000.0 in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $18.6 million in Q1 2025 to a low of -$252000.0 in Q4 2025.
- A 4-year average of $3.4 million and a median of $529000.0 in 2023 frame the typical range for Restructuring Costs.
- Peak annual rise in Restructuring Costs reached 13650.0% in 2025, while the deepest fall reached 445.21% in 2025.
- Tracing IRWD's Restructuring Costs over 4 years: stood at $621000.0 in 2023, then plunged by 88.24% to $73000.0 in 2024, then slumped by 445.21% to -$252000.0 in 2025, then surged by 84.13% to -$40000.0 in 2026.
- Business Quant data shows IRWD's Restructuring Costs at -$40000.0 in Q1 2026, -$252000.0 in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Ironwood Pharmaceuticals | 608.10 Mn | 387.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40,000.00 |
| Dec 31, 2025 | -252,000.00 |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | -250,000.00 |
| Mar 31, 2025 | 18.56 Mn |
| Dec 31, 2024 | 73,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 2.07 Mn |
| Mar 31, 2024 | 437,000.00 |
| Dec 31, 2023 | 621,000.00 |
| Sep 30, 2023 | 4.69 Mn |
| Jun 30, 2023 | 13.01 Mn |
| Sep 30, 2021 | -73,000.00 |
| Jun 30, 2021 | -282,000.00 |
| Mar 31, 2021 | 311,000.00 |
| Dec 31, 2020 | 14.15 Mn |
| Sep 30, 2020 | 1.23 Mn |
| Dec 31, 2019 | -32,000.00 |
| Sep 30, 2019 | -166,000.00 |
| Jun 30, 2019 | 490,000.00 |